ClinicalTrials.gg
Enrolling by invitationNCT07168798Updated Nov 21, 2025

SpO2 Accuracy in Children

An observational study in Hypoxemia, sponsored by Nihon Kohden. Enrolling by invitation at 1 site in United States. Open to participants aged 0 Days to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-21.

Sponsored by Nihon Kohden · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
180
Ages
0 Days to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Hypoxia by Nihon Kohden — 2 open to participants now, 4 under way, none of them phase 3. Hypoxia · Nihon Kohden.

Planned enrollment
Largest of 10
180 · median 12
Started
2025
with 1 other
Observational
10 of 10
2 open now
Registered
8th of 10
by date

Among the 10 studies in Hypoxia by Nihon Kohden, this one has the largest planned enrollment, is one of 2 that started in 2025, is one of 10 observational ones, and was the 8th registered.

Hypoxia

1,081 studies on the registry are indexed under Hypoxia; 213 are open to participants now.

Browse Hypoxia studies →

Open to participants now

2 of the 10 studies in Hypoxia by Nihon Kohden are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 124 Hypoxia studies recruiting now, 52 (42%) set no upper age limit and 46 (37%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 0 Days to 12 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Hypoxia by Nihon Kohden, or all of them as a file.
02

Study summary

Evaluation of SpO2 Accuracy in Children with Various Skin Color

Read the detailed description

Pulse oximeters, which estimate blood oxygen levels, are routinely utilized for monitoring. However, research has shown that these devices may provide higher readings for individuals with darker skin tones as compared to individuals with lighter skin tones. This inaccuracy can result in unnoticed or untreated low oxygen levels, particularly affecting racial and ethnic minorities. It is beneficial for patients and healthcare providers to evaluate the accuracy of pulse oximeter oxygen saturation (SpO2) readings from pulse oximeters sold in the U.S. This study test the Nihon Kohden pulse oximeter and SpO2 sensors in neonatal and pediatric patients.

03

Conditions studied

  • Hypoxemia

Browse trials for

Keywords

  • Spo2
  • Pulse oximetry
  • skin tone
04

Who can participate

Ages eligible
0 Days to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children in hospital setting

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 0 - 12 who are admitted to the CICU with or plan to have an indwelling arterial line for standard care

Exclusion criteria

Exclusion Criteria:

  • Patients with elevated levels of methemoglobin and carboxyhemoglobin, or anemia.
  • Patients with prolonged hypotension at the time of enrollment.
  • Patients with ductal-dependent congenital cardiac disease.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
180 participants (estimated)
Patient registry
No

Groups and cohorts

  • Enrolled subjects

    Subjects who meet the enrollment criteria

    Device: Pulse oximeter

Interventions

  • DevicePulse oximeter

    OLV-4201 pulse oximeter with sensors: TL-272T3, TL-274T3 and TL-273T3

06

What researchers measure

Primary outcomes

  1. SpO2 accuracy

    Evaluate the accuracy of Nihon Kohden SpO2 in measuring blood oxygen levels in children with varying skin tones

    Time frame: 24 hours

Secondary outcomes

  1. SpO2 to SaO2 agreement

    Evaluate the agreement between Nihon Kohden SpO2 and arterial oxygen saturation (SaO2) in children with varying skin tones

    Time frame: 24 hours

07

Study locations

1 site
08

References and documents

Publications

  • Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial Bias in Pulse Oximetry Measurement. N Engl J Med. 2020 Dec 17;383(25):2477-2478. doi: 10.1056/NEJMc2029240. No abstract available. PubMed 33326721 ↗

Individual participant data

Plan to share: No — Proprietary information

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2025 (actual). Primary completion is estimated for Nov 2027, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2025
First posted
Sep 11, 2025
StartActual
Nov 12, 2025
Primary completionEst.
Nov 1, 2027
CompletionEst.
Nov 1, 2028
Last update
Nov 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07168798
Lead sponsor
Nihon Kohden
Responsible party
Sponsor
First posted
Sep 11, 2025
Start date
Nov 12, 2025
Primary completion
Nov 1, 2027 (estimated)
Completion
Nov 1, 2028 (estimated)
Last update
Nov 21, 2025

Study contacts

Maryam Y Naim, M.D., MSCE
principal investigator · Children's Hospital of Philadelphia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion